660411-95-0 Usage
Uses
Used in Pharmaceutical Research:
5-Amino-1H-indazole-3-carboxylic acid methyl ester is used as a research compound for exploring its potential anti-cancer properties. It is believed to have antineoplastic effects, which could be beneficial in the development of new cancer treatments.
Used in Anti-inflammatory Studies:
5-Amino-1H-indazole-3-carboxylic acid methyl ester is also used as an anti-inflammatory agent in research settings. Its potential to reduce inflammation may lead to the discovery of new therapeutic approaches for inflammatory diseases.
Used in Laboratory Research and Development:
5-Amino-1H-indazole-3-carboxylic acid methyl ester is used as a synthetic compound in various laboratory experiments. Its properties are being studied to understand its potential applications in medicine and pharmaceuticals, including its possible role in drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 660411-95-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,0,4,1 and 1 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 660411-95:
(8*6)+(7*6)+(6*0)+(5*4)+(4*1)+(3*1)+(2*9)+(1*5)=140
140 % 10 = 0
So 660411-95-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H9N3O2/c1-14-9(13)8-6-4-5(10)2-3-7(6)11-12-8/h2-4H,10H2,1H3,(H,11,12)
660411-95-0Relevant academic research and scientific papers
1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS MAPKAP KINASE MODULATORS
-
Page/Page column 67-68, (2010/02/10)
The invention provides compounds of the formula: (I) for use in the prophylaxis or treatment of a disease state or condition mediated by a MAPKAP kinase: wherein A is a bond or a group CH2; R1 is a carbocyclic or heterocyclic group having from 3 to 12 ring members; R3, R4, R5 and R6 are the same or different and are each selected from hydrogen, halogen, hydroxy, trifluoromethyl, cyano, nitro, carboxy, amino, carbocyclic and heterocyclic groups having from 3 to 12 ring members; a group Ra -Rbwherein Ra is a bond, 0, CO, X1C(X2), C(X2)Xl, X1C(X2)X1, S, SO, S02, NRc, SO2NRc or NRcS02; and Rb is selected from hydrogen, carbocyclic and heterocyclic groups having from 3 to 12 ring members, and a C1-8 hydrocarbyl group optionally substituted by one or more substituents selected from hydroxy, oxo, halogen, cyano, nitro, amino, mono or di-C1-4 hydrocarbylamino, carbocyclic and heterocyclic groups having from 3 to 12 ring members and wherein one or more carbon atoms of the C1-8 hydrocarbyl group may optionally be replaced by 0, S, SO, SO2, NRc, X1C(X2), C(X2)X1 or X1C(X2)X1; Rc is hydrogen or C1-4hydrocarbyl; and X1 is O, S or NRc and X2 is =O, =S or =NRc.
